A. Menarini Farmaceutica Internazionale SRL has provided an educational grant for the production of this e-learning programme and has had no editorial control or input. The views and content expressed within this programme are solely those of the authors.
PP-CA-UK-0156 Date of preparation: March 2020
Designed to give healthcare professionals a current update on the treatment of angina, this is one of several modules in our angina programme.
Module first published: 06 July 2012
First revision of module published: 04 March 2015
Second revision of module published: 09 April 2020
2.5 CPD/CME credits
After completing this module, participants should become:
• Identify the objectives for secondary prevention and angina treatment
• Understand the mode of action and clinical profile of antianginal agents
• Know the treatment guidelines and when to use them appropriately
Dr Henry Purcell, Royal Brompton Hospital, London.
Dr Chris Arden, GPwSI in Cardiology, Park Surgery, Chandlers Ford, Southampton.
Module revised by Dr Richard Armstrong, Cardiology Research Fellow, St James Hospital, Dublin, Ireland; supervised by Dr Ranil De Silva, Senior Clinical Lecturer and Honorary Consultant Cardiologist, National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital, London.
2.5 CPD/CME credits, 2.5 hours
BJC Learning has assigned two and a half hours of CPD/CME credit to this module
Hyperlipidaemia Education & Atherosclerosis Research Trust
British Junior Cardiologists’ Association
You need to login to take this module
You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.